Deconstructing the mental health crisis: 5 uneasy pieces

Journal of Psychiatry and Neuroscience

Volumn 41, Issue 4, 2016, Pages 219-221

  Merali, Zul ^a   Anisman, Hymie ^b  

^a ROYAL OTTAWA HOSPITAL   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; NEUROLEPTIC AGENT; NUTRACEUTICAL; SEROTONIN UPTAKE INHIBITOR;

BIPOLAR DISORDER; BRAIN DEPTH STIMULATION; COMORBIDITY; DEPRESSION; EDITORIAL; HUMAN; MENTAL DISEASE; MENTAL DISEASE ASSESSMENT; MENTAL HEALTH; MENTAL HEALTH CARE; MENTAL HEALTH RESEARCH; NEUROMODULATION; PHENOTYPE; PHYSICAL DISEASE; SCHIZOPHRENIA; SHAME; SOCIAL STIGMA; TRANSCRANIAL MAGNETIC STIMULATION; ECONOMICS; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PATHOPHYSIOLOGY; PUBLIC-PRIVATE PARTNERSHIP;

BIOMEDICAL RESEARCH; BIOMEDICAL TECHNOLOGY; HUMANS; MENTAL DISORDERS; MENTAL HEALTH; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; SOCIAL STIGMA;

EID: 84977501846     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.160101     Document Type: Editorial

References (21)

1. Canadian Community Health Survey (CCHS) – mental health 2012. Statistics Canada, 2012.
2. Centre for Addiction and Mental Health. Mental Illness and Addictions: Facts and Statistics. 2012. Available: www.camh.ca/en/hospital/about_camh/newsroom/for_reporters/pages/addictionmentalhealthstatistics.aspx (accessed 2016 May 18).
3. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The global economic burden of non-communicable diseases. Geneva: World Economic Forum, 2011. Available: www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf (accessed 2016 May 18).
4. Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity of depression with neurodegenerative disorders. Prog Neurobiol 2008;85:1-74.
5. Lamb N. The NHS is ‘fragmented and dysfunctional’ says Norman Lamb MP. IndependentNurse, 17 May, 2016. Available: www.independentnurse.co.uk/news/norman-lamb-on-integration-of -mental-and-physical-health-care/140062 (accessed 2016 May 18).
6. Corrigan PW, Rafacz J, Rüsch N. Examining a progressive model of self-stigma and its impact on people with serious mental illness. Psychiatry Res 2011;189:339-43.
7. Chew-Graham CA, Rogers A, Yassin N. ‘I wouldn’t want it on my CV or their records’: medical students’ experiences of help-seeking for mental health problems. Med Educ 2003;37:873-80.
8. Thornicroft G, Mehta N, Clement S, et al. Evidence for effective interventions to reduce mental-health-related stigma and discrimination. Lancet 2016;387:1123-32.
9. Kirby M. Standing Senate Committee On Social Affairs, Science And Technology. Out of the shadows at last: transforming mental health, mental illness and addiction services in Canada. Final report of the Standing Senate Committee on Social Affairs, Science and Technology. 2006. Ottawa.
10. Hatcher S. The STAR*D trial: the 300 lb gorilla is in the room, but does it block all the light? Evid Based Ment Health 2008;11:97-9.
11. Warden D, Rush AJ, Trivedi MH, et al. The STAR*D project results: a comprehensive review of findings. Curr Psychiatry Rep 2007; 9:449-59.
12. Thase ME. STEP-BD and bipolar depression: What have we learned? Curr Psychiatry Rep 2007;9:497-503.
13. Glick ID. Understanding the results of CATIE in the context of the field. CNS Spectr 2006;11:40-7.
14. Sikich L, Frazier JA, McClellan J, et al. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry 2008;165:1420-31.
15. Vinkers CH, Kalafateli AL, Rutten BP, et al. Traumatic stress and human DNA methylation: a critical review. Epigenomics 2015;7: 593-608.
16. Alda M. Personalized psychiatry: many questions, fewer answers. J Psychiatry Neurosci 2013;38:363-5.
17. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013;11:126.
18. Kirmayer LJ, Crafa D. What kind of science for psychiatry? Front Hum Neurosci 2014;8:435.
19. Donker T, Petrie K, Proudfoot J, et al. Smartphones for smarter delivery of mental health programs: a systematic review. J Med Internet Res 2013;15:e247.
20. World Health Organization. (2016). Investing in treatment for depression and anxiety leads to fourfold return. Available: http://who.int/mediacentre/news/releases/2016/depression-anxiety-treatment/en/ (accessed 2016 Apr. 14).
21. Garau M, Mordoh A, Sussex J. Report for Cancer Research UK, exploring the interdependency between public and charitable medical research. April, 2011. Available: www.cancerresearchuk.org/sites/default/files/exploring_the_interdependency_b tween_public_andcharitable_medical_research.pdf (accessed 2016 May 18).